Diagnostic Medical Systems First Half 2023 Earnings: EPS: €0.24 (vs €0.18 loss in 1H 2022)

Diagnostic Medical Systems (EPA:ALDMS) First Half 2023 Results

Key Financial Results

• Revenue: €21.8m (up 15% from 1H 2022).
• Net income: €3.78m (up from €2.95m loss in 1H 2022).
• Profit margin: 17% (up from net loss in 1H 2022).
• EPS: €0.24 (up from €0.18 loss in 1H 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Diagnostic Medical Systems shares are down 4.6% from a week ago.

Risk Analysis

Be aware that Diagnostic Medical Systems is showing 3 warning signs in our investment analysis and 1 of those is significant...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.